A broadly neutralizing antibody protects against SARS-CoV, pre-emergent bat CoVs, and SARS-CoV-2 variants in mice

SARS-CoV in 2003, SARS-CoV-2 in 2019, and SARS-CoV-2 variants of concern (VOC) can cause deadly infections, underlining the importance of developing broadly effective countermeasures against Group 2B Sarbecoviruses, which could be key in the rapid prevention and mitigation of future zoonotic events....

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:bioRxiv
Egile Nagusiak: Martinez, David R., Schaefer, Alexandra, Gobeil, Sophie, Li, Dapeng, De la Cruz, Gabriela, Parks, Robert, Lu, Xiaozhi, Barr, Maggie, Manne, Kartik, Mansouri, Katayoun, Edwards, Robert J., Yount, Boyd, Anasti, Kara, Montgomery, Stephanie A., Shen, Shaunna, Zhou, Tongqing, Kwong, Peter D., Graham, Barney S., Mascola, John R., Montefiori, David. C., Alam, Munir, Sempowski, Gregory D., Wiehe, Kevin, Saunders, Kevin O., Acharya, Priyamvada, Haynes, Barton F., Baric, Ralph S.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Cold Spring Harbor Laboratory 2021
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8095197/
https://ncbi.nlm.nih.gov/pubmed/33948590
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2021.04.27.441655
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak